ROMAN: Phase 3 trial of avasopasem manganese (GC4419) for severe oral mucositis (SOM) in patients receiving chemoradiotherapy (CRT) for locally advanced, nonmetastatic head and neck cancer (LAHNC).

Carryn M. Anderson,Christopher M. Lee, Joseph Randall Kelley,Gary V. Walker,Neal E. Dunlap,Voichita C. Bar-Ad, Douglas A. Miller, Vernon J. King, Abhinand V. Peddada, Douglas F. Ciuba,Francois Vincent, Brian C. Muzyka, Amanda Lynn Gillespie-Twardy,Stephen T. Sonis,Jon Holmlund,Deborah Saunders

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 8|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要